Company news
Cytek Biosciences, Inc. (NASDAQ:CTKB) news
Every Cytek Biosciences, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding
August 21, 2026
Cytek Biosciences Reports Second Quarter 2026 Financial Results
August 5, 2026
Cytek Biosciences to Report Second Quarter 2026 Financial Results on August 5, 2026
July 22, 2026
Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement
July 15, 2026
Cytek Biosciences to participate at the Singular Research’s Las Vegas Invitational Conference
June 10, 2026
Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026
June 2, 2026
Cytek Biosciences Reports First Quarter 2026 Financial Results
May 7, 2026
Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026
April 23, 2026
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact
March 9, 2026
Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook
February 26, 2026
Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook
February 26, 2026
Cytek Biosciences to participate at the TD Cowen 46th Annual Health Care Conference
February 18, 2026
Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
February 12, 2026
Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results
January 12, 2026
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
November 12, 2025
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
November 6, 2025
Cytek Biosciences to Participate in Upcoming Investor Conferences
November 6, 2025
Cytek Biosciences Reports Third Quarter 2025 Financial Results
November 5, 2025
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
October 29, 2025
Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025
October 22, 2025
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth
October 15, 2025
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
September 10, 2025
Cytek Biosciences Reports Second Quarter 2025 Financial Results
August 6, 2025
Cytek Biosciences to Report Second Quarter 2025 Financial Results on August 6, 2025
July 23, 2025
Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change
July 3, 2025
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
May 29, 2025
Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference
May 28, 2025
Cytek Biosciences Reports First Quarter 2025 Financial Results
May 8, 2025
Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
April 29, 2025
Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025
April 24, 2025
Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System
March 18, 2025
Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook
February 27, 2025
Cytek Biosciences Announces Preliminary Full Year 2024 Revenue Results
January 15, 2025
Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference
January 2, 2025
Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025
December 30, 2024
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
November 7, 2024
Cytek Biosciences Reports Third Quarter 2024 Financial Results
November 5, 2024
Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024
October 29, 2024
Cytek Announces Resignation of Chief Operating Officer Chris Williams
September 12, 2024
Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
August 21, 2024
Cytek Biosciences Reports Second Quarter 2024 Financial Results
August 6, 2024
Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm
July 30, 2024
Cytek Biosciences Announces $50 Million Stock Repurchase Program
June 6, 2024
Cytek Biosciences Reports First Quarter 2024 Financial Results
May 8, 2024
Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe
April 30, 2024
Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024
April 29, 2024
Cytek® Biosciences Names William McCombe Chief Financial Officer
March 19, 2024
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions
March 7, 2024
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
February 28, 2024
Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
February 7, 2024